Krishan Kumar

Pfizer (United States)

Papers

1

Total Citations

86

H-Index

1

About

Dr. Krishan Kumar is a leading voice at the intersection of pharmaceutical safety and artificial intelligence, whose work is reshaping the operational backbone of pharmacovigilance. His primary research focuses on leveraging AI and robotic process automation to streamline adverse event case processing—historically the most significant cost driver in drug safety budgets. Kumar’s landmark 2018 study, cited over 86 times, demonstrated the first successful pilot of AI-driven automation in this domain, proving that machines could reliably handle the complex, high-volume data entry and triage tasks traditionally performed by human safety specialists. This contribution has not only offered a roadmap for reducing industry costs but has also improved data accuracy and patient safety response times. By bridging the gap between clinical vigilance and cutting-edge technology, Kumar has established himself as a pivotal figure in modern pharmacovigilance innovation, influencing how global pharmaceutical companies now approach regulatory compliance and risk management.

Research Focus

Key Achievements

1
H-Index
1
Papers
86
Total Citations
86
Avg Citations/Paper
🏆 Most Cited Paper
Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing
86 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago